Skip to main content

Single Cell Technologies for SMEs

Objective

This project is focused on development of technologies for separation and manipulation of single biological cells for life science research and medical applications. The research plan is built upon the results of the FP7 project PASCA (GA 257073, started 01.09.2010). The single cell manipulation technology (SCM technology) developed there is based on inkjet-like printing of single biological cells confined in free flying micro droplets. It constitutes a universal platform for single cell analysis that has been proven to have high potential for many life science applications. The objective of this project is to support the participating SMEs and companies to take up the SCM technology, to realize their own applications and to develop them into innovative products for the medical, biomedical and pharmaceutical markets. Central element of the research is the SCM prototype instrument as presented in numerous publications (see www.pasca.eu). The actual project will provide validation and extension of the use of this prototype instrument and deal with necessary improvements and modifications of pre-production prototypes towards the specific needs and applications of the SME partners. In particular also topics affecting commercial exploitation like e.g. application development, design for manufacturability, reliability issues, cost and throughput optimization, extension of technical specifications, and preparation of CE IVD labeling will be investigated. Applications targeted by the individual SMEs are considering fast pathogen detection for clinical use by combining the SCM technology with MALDI TOF mass spectroscopy of single bacteria, instruments for single cell cancer and stem cell research, methods for monoclonal cell line development and in-vitro medical diagnostic applications. The anticipated innovations stemming from this research will be exploited by the involved SMEs individually as well as jointly through several innovative products targeted for different markets and applications.

Call for proposal

FP7-SME-2013
See other projects for this call

Coordinator

BIOFLUIDIX GMBH
Address
George Koehler Allee 106 106
79110 Freiburg Im Breisgau
Germany
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 238 000
Administrative Contact
Wolfgang Streule (Dr.)

Participants (6)

BIOSPARQ BV
Netherlands
EU contribution
€ 273 750
Address
Galileiweg 8
2333 BD Leiden
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Gerold De Valk (Mr.)
PRIMADIAG SAS
France
EU contribution
€ 315 000
Address
Avenue Gaston Roussel 102 Parc Biocitech
93230 Romainville
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Guillaume L'hermite (Mr.)
Innovative Technologies in Biological Systems
Spain
EU contribution
€ 93 000
Address
Parque Tecnologico De Bizkaia 502-1
48160 Derio
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Isbaal Ramos (Mr.)
SOPHION BIOSCIENCE A/S
Denmark
EU contribution
€ 107 250
Address
Baltorpvej
2750 Ballerup
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Claus Kock-Nielsen (Mr.)
ALBERT-LUDWIGS-UNIVERSITAET FREIBURG
Germany
EU contribution
€ 6 000
Address
Fahnenbergplatz
79098 Freiburg
Activity type
Higher or Secondary Education Establishments
Administrative Contact
André Groß (Mr.)
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Netherlands
EU contribution
€ 6 000
Address
Dr Molewaterplein 40
3015 GD Rotterdam
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Willem Van Leeuwen (Dr.)